Literature DB >> 32719008

Super-rapid quantitation of the production of HIV-1 harboring a luminescent peptide tag.

Seiya Ozono1,2, Yanzhao Zhang1, Minoru Tobiume1, Satoshi Kishigami2, Kenzo Tokunaga3.   

Abstract

In studies of HIV-1, virus production is normally monitored by either a reverse transcriptase assay or a p24 antigen capture ELISA. However, these assays are costly and time-consuming for routine handling of a large number of HIV-1 samples. For example, sample dilution is always required in the ELISA procedure to determine p24 protein levels because of the very narrow range of detectable concentrations in this assay. Here, we establish a novel HIV-1 production assay system to solve the aforementioned problems by using a recently developed small peptide tag called HiBiT. This peptide is a fragment of NanoLuc luciferase and generates a strong luminescent signal when complemented with the remaining subunit. To employ this technology, we constructed a novel full-length proviral HIV-1 DNA clone and a lentiviral packaging vector in which the HiBiT tag was added to the C terminus of the integrase. Tagging the integrase with the HiBiT sequence did not impede the resultant virus production, infectivity, or susceptibility to an integrase inhibitor. EM revealed normal morphology of the virus particles. Most importantly, by comparing between ELISA and the HiBiT luciferase assay, we successfully obtained an excellent linear correlation between p24 concentrations and HiBiT-based luciferase activity. Overall, we conclude that HiBiT-tagged viruses can replace the parental HIV-1 and lentiviral vectors, which enables us to perform a super-rapid, inexpensive, convenient, simple, and highly accurate quantitative assay for HIV-1/lentivirus production. This system can be widely applied to a variety of virological studies, along with screening for candidates of future antiviral drugs.
© 2020 Ozono et al.

Entities:  

Keywords:  HIV-1; Vif; human immunodeficiency virus (HIV); infection; integrase; luminescent peptide tag; quantitation; viral protein; viral replication; virology

Year:  2020        PMID: 32719008      PMCID: PMC7489901          DOI: 10.1074/jbc.RA120.013887

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference.

Authors:  Maciej Wiznerowicz; Didier Trono
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

2.  NanoLuc Complementation Reporter Optimized for Accurate Measurement of Protein Interactions in Cells.

Authors:  Andrew S Dixon; Marie K Schwinn; Mary P Hall; Kris Zimmerman; Paul Otto; Thomas H Lubben; Braeden L Butler; Brock F Binkowski; Thomas Machleidt; Thomas A Kirkland; Monika G Wood; Christopher T Eggers; Lance P Encell; Keith V Wood
Journal:  ACS Chem Biol       Date:  2015-12-10       Impact factor: 5.100

Review 3.  Real-time quantitative PCR for the design of lentiviral vector analytical assays.

Authors:  C Delenda; C Gaillard
Journal:  Gene Ther       Date:  2005-10       Impact factor: 5.250

4.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

5.  Antigenemia and antibody titers to core and envelope antigens in AIDS, AIDS-related complex, and subclinical human immunodeficiency virus infection.

Authors:  J Goudsmit; J M Lange; D A Paul; G J Dawson
Journal:  J Infect Dis       Date:  1987-03       Impact factor: 5.226

6.  Monocyte-derived cultured dendritic cells are susceptible to human immunodeficiency virus infection and transmit virus to resting T cells in the process of nominal antigen presentation.

Authors:  Y Tsunetsugu-Yokota; K Akagawa; H Kimoto; K Suzuki; M Iwasaki; S Yasuda; G Häusser; C Hultgren; A Meyerhans; T Takemori
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

7.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

8.  Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.

Authors:  Rebecca A Russell; Vinay K Pathak
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

9.  All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition.

Authors:  Masanobu Kinomoto; Takayuki Kanno; Mari Shimura; Yukihito Ishizaka; Asato Kojima; Takeshi Kurata; Tetsutaro Sata; Kenzo Tokunaga
Journal:  Nucleic Acids Res       Date:  2007-04-16       Impact factor: 16.971

10.  Comparison of lentiviral vector titration methods.

Authors:  Martine Geraerts; Sofie Willems; Veerle Baekelandt; Zeger Debyser; Rik Gijsbers
Journal:  BMC Biotechnol       Date:  2006-07-12       Impact factor: 2.563

View more
  8 in total

1.  Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike.

Authors:  Daichi Yamasoba; Izumi Kimura; Hesham Nasser; Yuhei Morioka; Naganori Nao; Jumpei Ito; Keiya Uriu; Masumi Tsuda; Jiri Zahradnik; Kotaro Shirakawa; Rigel Suzuki; Mai Kishimoto; Yusuke Kosugi; Kouji Kobiyama; Teppei Hara; Mako Toyoda; Yuri L Tanaka; Erika P Butlertanaka; Ryo Shimizu; Hayato Ito; Lei Wang; Yoshitaka Oda; Yasuko Orba; Michihito Sasaki; Kayoko Nagata; Kumiko Yoshimatsu; Hiroyuki Asakura; Mami Nagashima; Kenji Sadamasu; Kazuhisa Yoshimura; Jin Kuramochi; Motoaki Seki; Ryoji Fujiki; Atsushi Kaneda; Tadanaga Shimada; Taka-Aki Nakada; Seiichiro Sakao; Takuji Suzuki; Takamasa Ueno; Akifumi Takaori-Kondo; Ken J Ishii; Gideon Schreiber; Hirofumi Sawa; Akatsuki Saito; Takashi Irie; Shinya Tanaka; Keita Matsuno; Takasuke Fukuhara; Terumasa Ikeda; Kei Sato
Journal:  Cell       Date:  2022-05-02       Impact factor: 66.850

2.  Generation of a bovine cell line for gene engineering using an HIV-1-based lentiviral vector.

Authors:  Nanami Morizako; Erika P Butlertanaka; Yuri L Tanaka; Honoka Shibata; Tamaki Okabayashi; Hirohisa Mekata; Akatsuki Saito
Journal:  Sci Rep       Date:  2022-10-18       Impact factor: 4.996

3.  SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.

Authors:  Chihiro Motozono; Mako Toyoda; Jiri Zahradnik; Akatsuki Saito; Hesham Nasser; Toong Seng Tan; Isaac Ngare; Izumi Kimura; Keiya Uriu; Yusuke Kosugi; Yuan Yue; Ryo Shimizu; Jumpei Ito; Shiho Torii; Akiko Yonekawa; Nobuyuki Shimono; Yoji Nagasaki; Rumi Minami; Takashi Toya; Noritaka Sekiya; Takasuke Fukuhara; Yoshiharu Matsuura; Gideon Schreiber; Terumasa Ikeda; So Nakagawa; Takamasa Ueno; Kei Sato
Journal:  Cell Host Microbe       Date:  2021-06-15       Impact factor: 21.023

4.  MARCH8 Targets Cytoplasmic Lysine Residues of Various Viral Envelope Glycoproteins.

Authors:  Yanzhao Zhang; Seiya Ozono; Takuya Tada; Minoru Tobiume; Masanori Kameoka; Satoshi Kishigami; Hideaki Fujita; Kenzo Tokunaga
Journal:  Microbiol Spectr       Date:  2022-01-12

5.  Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation.

Authors:  Akatsuki Saito; Takashi Irie; Rigel Suzuki; Tadashi Maemura; Hesham Nasser; Keiya Uriu; Yusuke Kosugi; Kotaro Shirakawa; Kenji Sadamasu; Izumi Kimura; Jumpei Ito; Jiaqi Wu; Kiyoko Iwatsuki-Horimoto; Mutsumi Ito; Seiya Yamayoshi; Samantha Loeber; Masumi Tsuda; Lei Wang; Seiya Ozono; Erika P Butlertanaka; Yuri L Tanaka; Ryo Shimizu; Kenta Shimizu; Kumiko Yoshimatsu; Ryoko Kawabata; Takemasa Sakaguchi; Kenzo Tokunaga; Isao Yoshida; Hiroyuki Asakura; Mami Nagashima; Yasuhiro Kazuma; Ryosuke Nomura; Yoshihito Horisawa; Kazuhisa Yoshimura; Akifumi Takaori-Kondo; Masaki Imai; Shinya Tanaka; So Nakagawa; Terumasa Ikeda; Takasuke Fukuhara; Yoshihiro Kawaoka; Kei Sato
Journal:  Nature       Date:  2021-11-25       Impact factor: 49.962

6.  Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5.

Authors:  Izumi Kimura; Daichi Yamasoba; Tomokazu Tamura; Naganori Nao; Tateki Suzuki; Yoshitaka Oda; Shuya Mitoma; Jumpei Ito; Hesham Nasser; Jiri Zahradnik; Keiya Uriu; Shigeru Fujita; Yusuke Kosugi; Lei Wang; Masumi Tsuda; Mai Kishimoto; Hayato Ito; Rigel Suzuki; Ryo Shimizu; Mst Monira Begum; Kumiko Yoshimatsu; Kanako Terakado Kimura; Jiei Sasaki; Kaori Sasaki-Tabata; Yuki Yamamoto; Tetsuharu Nagamoto; Jun Kanamune; Kouji Kobiyama; Hiroyuki Asakura; Mami Nagashima; Kenji Sadamasu; Kazuhisa Yoshimura; Kotaro Shirakawa; Akifumi Takaori-Kondo; Jin Kuramochi; Gideon Schreiber; Ken J Ishii; Takao Hashiguchi; Terumasa Ikeda; Akatsuki Saito; Takasuke Fukuhara; Shinya Tanaka; Keita Matsuno; Kei Sato
Journal:  Cell       Date:  2022-09-14       Impact factor: 66.850

Review 7.  Detecting SARS-CoV-2 neutralizing immunity: highlighting the potential of split nanoluciferase technology.

Authors:  Sundararaj Stanleyraj Jeremiah; Kei Miyakawa; Akihide Ryo
Journal:  J Mol Cell Biol       Date:  2022-08-17       Impact factor: 8.185

8.  Phenotypic and Genotypic Co-receptor Tropism Testing in HIV-1 Epidemic Region of Tanzania Where Multiple Non-B Subtypes Co-circulate.

Authors:  George P Judicate; Godfrey Barabona; Doreen Kamori; Macdonald Mahiti; Toong Seng Tan; Seiya Ozono; Amina Shaban Mgunya; Takeo Kuwata; Shuzo Matsushita; Bruno Sunguya; Eligius Lyamuya; Kenzo Tokunaga; Takamasa Ueno
Journal:  Front Microbiol       Date:  2021-07-07       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.